Pathophysiology of cystic fibrosis lung disease

Marcus A. Mall, Richard C. Boucher

Source: Eur Respir Monogr 2014; 64: 1-13
Journal Issue: Cystic Fibrosis
Disease area: Airway diseases

Full text journal articleCongress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marcus A. Mall, Richard C. Boucher. Pathophysiology of cystic fibrosis lung disease. Eur Respir Monogr 2014; 64: 1-13

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Early cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 77-87
Year: 2014


The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2019; 83: 158-172
Year: 2019


Update on pancreatic and liver disease in cystic fibrosis
Source: Virtual Congress 2020 – Updates in cystic fibrosis
Year: 2020


Lung function in children with cystic fibrosis liver disease
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021


Relations between the sinonasal development and the lung disease in cystic fibrosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 103s
Year: 2005

Practical microbiology of cystic fibrosis lung disease
Source: School Course 2013 - Cystic Fibrosis
Year: 2013

Cystic fibrosis lung disease and lung transplantation
Source: ERS Skills Course 2016
Year: 2016

Early determinants of lung disease in children with cystic fibrosis
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020




Significance of histopathologic features suggesting connective tissue disease in idiopathic pulmonary fibrosis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Antibiotic treatment of cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 188-202
Year: 2014


Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease
Source: Eur Respir J, 57 (2) 2003079; 10.1183/13993003.03079-2020
Year: 2021



Variation in mortality from interstitial lung disease by diagnosis
Source: International Congress 2015 – IIPs: orphan
Year: 2015


Diagnosing bronchiectasis and cystic fibrosis
Source: International Congress 2018 – ME8 Diagnosing bronchiectasis and cystic fibrosis
Year: 2018


Early origin of cystic fibrosis lung disease
Source: Annual Congress 2010 - Early origins of adult lung disease
Year: 2010


Update on management of lung infection in cystic fibrosis
Source: Virtual Congress 2020 – Updates in cystic fibrosis
Year: 2020